A patient with oligometastatic hormone‐sensitive prostate cancer who achieved long‐term progression‐free survival following cytoreductive radical prostatectomy and metastasectomy

• Published in: IJU case reports Vol. 7; no. 2; pp. 165 - 168
• Main Authors: Mamiya, Daisuke, Kijima, Toshiki, Takada‐Owada, Atsuko, Kokubun, Hidetoshi, Uematsu, Toshitaka, Takei, Kohei, Kambara, Tsunehito, Ishida, Kazuyuki, Taneichi, Hiroshi, Kamai, Takao
• Format: Journal Article
• Language: English
• Published: Australia John Wiley & Sons, Inc 01.03.2024; John Wiley and Sons Inc; Wiley
• Subjects: Androgens; Bone marrow; Cancer therapies; Case Report; Case Reports; Conflicts of interest; cytoreductive surgery; Fractures; Lymphatic system; Magnetic resonance imaging; Medical prognosis; metastasectomy; Metastasis; oligometastasis; Patients; progression‐free survival; Prostate cancer; Radiation therapy; Scintigraphy; Supervision; Tomography; Writing; prostate cancer; oligometastasis; metastasectomy; cytoreductive surgery; progression‐free survival

Introduction Oligometastatic prostate cancer can be well‐controlled through combined local and metastasis‐directed therapies. However, the effects of cytoreductive radical prostatectomy and metastasectomy remain unclear. Case presentation A 52‐year‐old man presented with prostate cancer and isolated...